526 related articles for article (PubMed ID: 27064363)
21. A novel small molecule inhibitor of the DNA repair protein Ku70/80.
Weterings E; Gallegos AC; Dominick LN; Cooke LS; Bartels TN; Vagner J; Matsunaga TO; Mahadevan D
DNA Repair (Amst); 2016 Jul; 43():98-106. PubMed ID: 27130816
[TBL] [Abstract][Full Text] [Related]
22. HDAC inhibitors suppress protein poly(ADP-ribosyl)ation and DNA repair protein levels and phosphorylation status in hematologic cancer cells: implications for their use in combination with PARP inhibitors and chemotherapeutic drugs.
Valdez BC; Nieto Y; Yuan B; Murray D; Andersson BS
Oncotarget; 2022 Oct; 13():1122-1135. PubMed ID: 36243940
[TBL] [Abstract][Full Text] [Related]
23. Marked contribution of alternative end-joining to chromosome-translocation-formation by stochastically induced DNA double-strand-breaks in G2-phase human cells.
Soni A; Siemann M; Pantelias GE; Iliakis G
Mutat Res Genet Toxicol Environ Mutagen; 2015 Nov; 793():2-8. PubMed ID: 26520366
[TBL] [Abstract][Full Text] [Related]
24. Ubiquitylation of Ku80 by RNF126 Promotes Completion of Nonhomologous End Joining-Mediated DNA Repair.
Ishida N; Nakagawa T; Iemura SI; Yasui A; Shima H; Katoh Y; Nagasawa Y; Natsume T; Igarashi K; Nakayama K
Mol Cell Biol; 2017 Feb; 37(4):. PubMed ID: 27895153
[TBL] [Abstract][Full Text] [Related]
25. Super-resolution imaging identifies PARP1 and the Ku complex acting as DNA double-strand break sensors.
Yang G; Liu C; Chen SH; Kassab MA; Hoff JD; Walter NG; Yu X
Nucleic Acids Res; 2018 Apr; 46(7):3446-3457. PubMed ID: 29447383
[TBL] [Abstract][Full Text] [Related]
26. DNA Double Strand Break Response and Limited Repair Capacity in Mouse Elongated Spermatids.
Ahmed EA; Scherthan H; de Rooij DG
Int J Mol Sci; 2015 Dec; 16(12):29923-35. PubMed ID: 26694360
[TBL] [Abstract][Full Text] [Related]
27. Sensitizing thermochemotherapy with a PARP1-inhibitor.
Oei AL; Vriend LE; van Leeuwen CM; Rodermond HM; Ten Cate R; Westermann AM; Stalpers LJ; Crezee J; Kanaar R; Kok HP; Krawczyk PM; Franken NA
Oncotarget; 2017 Mar; 8(10):16303-16312. PubMed ID: 27557507
[TBL] [Abstract][Full Text] [Related]
28. Parp1-Dependent DNA Double-Strand Break Repair in Irradiated Late Pachytene Spermatocytes.
Ahmed EA; Alzahrani AM; Scherthan H
DNA Cell Biol; 2021 Feb; 40(2):209-218. PubMed ID: 33337266
[TBL] [Abstract][Full Text] [Related]
29. IER5 is involved in DNA Double-Strand Breaks Repair in Association with PAPR1 in Hela Cells.
Yu XP; Wu YM; Liu Y; Tian M; Wang JD; Ding KK; Ma T; Zhou PK
Int J Med Sci; 2017; 14(12):1292-1300. PubMed ID: 29104487
[TBL] [Abstract][Full Text] [Related]
30. BCL2-overexpressing prostate cancer cells rely on PARP1-dependent end-joining and are sensitive to combined PARP inhibitor and radiation therapy.
Oing C; Tennstedt P; Simon R; Volquardsen J; Borgmann K; Bokemeyer C; Petersen C; Dikomey E; Rothkamm K; Mansour WY
Cancer Lett; 2018 Jun; 423():60-70. PubMed ID: 29526801
[TBL] [Abstract][Full Text] [Related]
31. Olaparib modulates DNA repair efficiency, sensitizes cervical cancer cells to cisplatin and exhibits anti-metastatic property.
Prasad CB; Prasad SB; Yadav SS; Pandey LK; Singh S; Pradhan S; Narayan G
Sci Rep; 2017 Oct; 7(1):12876. PubMed ID: 28993682
[TBL] [Abstract][Full Text] [Related]
32. Curcumin suppresses multiple DNA damage response pathways and has potency as a sensitizer to PARP inhibitor.
Ogiwara H; Ui A; Shiotani B; Zou L; Yasui A; Kohno T
Carcinogenesis; 2013 Nov; 34(11):2486-97. PubMed ID: 23825154
[TBL] [Abstract][Full Text] [Related]
33. Alternative NHEJ Pathway Components Are Therapeutic Targets in High-Risk Neuroblastoma.
Newman EA; Lu F; Bashllari D; Wang L; Opipari AW; Castle VP
Mol Cancer Res; 2015 Mar; 13(3):470-82. PubMed ID: 25563294
[TBL] [Abstract][Full Text] [Related]
34. Non-homologous end joining, but not homologous recombination, enables survival for cells exposed to a histone deacetylase inhibitor.
Yaneva M; Li H; Marple T; Hasty P
Nucleic Acids Res; 2005; 33(16):5320-30. PubMed ID: 16177181
[TBL] [Abstract][Full Text] [Related]
35. Cloning, localization and focus formation at DNA damage sites of canine Ku70.
Koike M; Yutoku Y; Koike A
J Vet Med Sci; 2017 Mar; 79(3):554-561. PubMed ID: 28163277
[TBL] [Abstract][Full Text] [Related]
36. Targeted Cancer Therapy Based on Acetylation and Deacetylation of Key Proteins Involved in Double-Strand Break Repair.
Wang X; Zhao J
Cancer Manag Res; 2022; 14():259-271. PubMed ID: 35115826
[TBL] [Abstract][Full Text] [Related]
37. Rational combination therapy for hepatocellular carcinoma with PARP1 and DNA-PK inhibitors.
Wang C; Tang H; Geng A; Dai B; Zhang H; Sun X; Chen Y; Qiao Z; Zhu H; Yang J; Chen J; He Q; Qin N; Xie J; Tan R; Wan X; Gao S; Jiang Y; Sun FL; Mao Z
Proc Natl Acad Sci U S A; 2020 Oct; 117(42):26356-26365. PubMed ID: 33020270
[TBL] [Abstract][Full Text] [Related]
38. Repair of G1 induced DNA double-strand breaks in S-G2/M by alternative NHEJ.
Yu W; Lescale C; Babin L; Bedora-Faure M; Lenden-Hasse H; Baron L; Demangel C; Yelamos J; Brunet E; Deriano L
Nat Commun; 2020 Oct; 11(1):5239. PubMed ID: 33067475
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of histone deacetylases enhances DNA damage repair in SCNT embryos.
Bohrer RC; Duggavathi R; Bordignon V
Cell Cycle; 2014; 13(13):2138-48. PubMed ID: 24841373
[TBL] [Abstract][Full Text] [Related]
40. PREVENTING THE CHROMOSOMAL TRANSLOCATIONS THAT CAUSE CANCER.
Hromas R; Williamson E; Lee SH; Nickoloff J
Trans Am Clin Climatol Assoc; 2016; 127():176-195. PubMed ID: 28066052
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
